Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing pantoprazole (a proton pump inhibitor) and the antibiotics amoxicillin and clarithromycin, used for the eradication of *Helicobacter pylori* infection.
## Primary Indications
* Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The typical adult dose is one triple-pack taken twice daily for 7 to 14 days. Each triple-pack contains:
* Pantoprazole 40 mg
* Amoxicillin 500 mg
* Clarithromycin 500 mg
**Important:** Dosing duration and exact formulation may vary based on local guidelines and prescriber preference.
## Pediatric Dosing
* Pediatric dosing for Sompraz HP is not well-established. Dosing should be individualized by a qualified prescriber, often using separate components of the regimen.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment for pantoprazole is typically needed in mild to moderate renal impairment. However, caution and potential dose adjustment may be considered in severe renal impairment. Amoxicillin clearance is reduced in renal impairment; dose adjustment is necessary. Clarithromycin requires dose adjustment in severe renal impairment.
* **Hepatic Impairment:** Dose adjustment for pantoprazole may be necessary in severe hepatic impairment. Clarithromycin also requires dose adjustment in moderate to severe hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of cholestatic jaundice or hepatic dysfunction associated with previous clarithromycin use.
* Severe renal impairment with creatinine clearance less than 30 mL/min (for amoxicillin component).
* Concomitant use with ergotamine or dihydroergotamine (due to clarithromycin).
* Patients with a known history of torsades de pointes, prolonged QT interval, electrolyte imbalance, bradycardia, or significant cardiac disease (due to clarithromycin).
## Adverse Effects
Common adverse effects include diarrhea, nausea, abdominal pain, headache, rash, and taste perversion.
Serious adverse effects can include severe allergic reactions, *Clostridioides difficile*-associated diarrhea, QT prolongation, hepatotoxicity, and Stevens-Johnson syndrome.
## Key Drug Interactions
* **Clarithromycin:** Can inhibit CYP3A4, leading to increased levels of numerous drugs (e.g., statins, calcium channel blockers, warfarin, cyclosporine, tacrolimus, certain benzodiazepines, colchicine). **Avoid co-administration with ergot derivatives.** May increase the plasma concentration of sildenafil.
* **Pantoprazole:** May decrease the absorption of drugs that require acidic environments (e.g., ketoconazole, itraconazole, iron salts, vitamin B12). May alter the absorption of certain antiretrovirals.
* **Amoxicillin:** Can decrease the efficacy of oral contraceptives. Probenecid may decrease the renal excretion of amoxicillin.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Monitor for diarrhea, particularly *C. difficile*-associated diarrhea.
* Assess for signs of hepatotoxicity.
* Monitor patients with prolonged QT risk factors for changes in ECG.
* Evaluate therapeutic response to confirm *H. pylori* eradication post-treatment (typically via urea breath test or stool antigen test).
## Clinical Pearls
* Administer the entire contents of the triple-pack twice daily, typically before breakfast and before the evening meal.
* Complete the full course of therapy as prescribed, even if symptoms improve.
* Ensure patients are not allergic to penicillin or macrolide antibiotics.
* Counsel patients on potential drug interactions, especially with clarithromycin.
***
**Disclaimer:** This information is intended for clinical pharmacists and healthcare professionals. It is not a substitute for comprehensive drug information resources or professional judgment. Always consult the most current prescribing information and relevant clinical guidelines before making therapeutic decisions.
